Rosemont is a highly specialised pharmaceutical business developing and manufacturing oral liquid formulations of off-patent solid dose pharmaceutical products.

Rosemont's products are prescribed to patients who are unable to take solid dose medicines due to dysphagia or swallowing difficulties. Most of these patients are the elderly or the very young.

Rosemont currently produces over 100 licensed and special products and continues to develop new products.  It is the clear market leader in the UK and growing internationally.